93 related articles for article (PubMed ID: 10647795)
1. Human papillomavirus antibody and risk of prostate cancer.
Hisada M; Rabkin CS; Strickler HD; Wright WE; Christianson RE; van den Berg BJ
JAMA; 2000 Jan; 283(3):340-1. PubMed ID: 10647795
[No Abstract] [Full Text] [Related]
2. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study.
Adami HO; Kuper H; Andersson SO; Bergström R; Dillner J
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):872-5. PubMed ID: 14504197
[TBL] [Abstract][Full Text] [Related]
3. HPV persistence and its oncogenic role in prostate tumors.
Tachezy R; Hrbacek J; Heracek J; Salakova M; Smahelova J; Ludvikova V; Svec A; Urban M; Hamsikova E
J Med Virol; 2012 Oct; 84(10):1636-45. PubMed ID: 22930513
[TBL] [Abstract][Full Text] [Related]
4. Role of antibodies to human papillomavirus 16 in prostate cancer: A seroscreening by peptide microarray.
Zhao X; Zhou Z; Chen Y; Chen W; Ma H; Pu J
Tumour Biol; 2017 Jun; 39(6):1010428317698371. PubMed ID: 28618964
[TBL] [Abstract][Full Text] [Related]
5. A multifaceted study of human papillomavirus and prostate carcinoma.
Strickler HD; Burk R; Shah K; Viscidi R; Jackson A; Pizza G; Bertoni F; Schiller JT; Manns A; Metcalf R; Qu W; Goedert JJ
Cancer; 1998 Mar; 82(6):1118-25. PubMed ID: 9506358
[TBL] [Abstract][Full Text] [Related]
6. No high-risk human papillomavirus infection in prostate cancer tissues.
Smelov V; van Moorselaar J; Startsev V; Smelova N; Grigorovich E; Meijer C; Morré S
Scand J Infect Dis; 2011 May; 43(5):399-400. PubMed ID: 21250904
[No Abstract] [Full Text] [Related]
7. Molecular genetics and epidemiology of prostate carcinoma.
Ruijter E; van de Kaa C; Miller G; Ruiter D; Debruyne F; Schalken J
Endocr Rev; 1999 Feb; 20(1):22-45. PubMed ID: 10047972
[No Abstract] [Full Text] [Related]
8. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers.
Gillison ML; Shah KV
J Natl Cancer Inst Monogr; 2003; (31):57-65. PubMed ID: 12807947
[TBL] [Abstract][Full Text] [Related]
9. The role of human papillomavirus infection in prostate cancer.
Al-Maghrabi JA
Saudi Med J; 2007 Mar; 28(3):326-33. PubMed ID: 17334454
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil.
Silvestre RV; Leal MF; Demachki S; Nahum MC; Bernardes JG; Rabenhorst SH; Smith Mde A; Mello WA; Guimarães AC; Burbano RR
Mem Inst Oswaldo Cruz; 2009 Jul; 104(4):665-7. PubMed ID: 19722096
[TBL] [Abstract][Full Text] [Related]
11. [Immunological tests: Antibodies to human papillomavirus type 16 L1-capsids].
Matsumoto K
Nihon Rinsho; 2005 Jul; 63 Suppl 7():326-8. PubMed ID: 16111264
[No Abstract] [Full Text] [Related]
12. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.
Bello D; Webber MM; Kleinman HK; Wartinger DD; Rhim JS
Carcinogenesis; 1997 Jun; 18(6):1215-23. PubMed ID: 9214605
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Type Distribution of Human Papilloma Virus in Patients with Prostate Cancer, Kerman, Southeast of Iran.
Atashafrooz F; Rokhbakhsh-Zamin F
Asian Pac J Cancer Prev; 2016; 17(8):3953-8. PubMed ID: 27644644
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
Korodi Z; Dillner J; Jellum E; Lumme S; Hallmans G; Thoresen S; Hakulinen T; Stattin P; Luostarinen T; Lehtinen M; Hakama M
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2952-5. PubMed ID: 16365015
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers.
Serth J; Panitz F; Paeslack U; Kuczyk MA; Jonas U
Cancer Res; 1999 Feb; 59(4):823-5. PubMed ID: 10029070
[TBL] [Abstract][Full Text] [Related]
16. The probability of involvement of human papillomavirus in the carcinogenesis of bladder small cell carcinoma, prostatic ductal adenocarcinoma, and penile squamous cell carcinoma: a case report.
Ogawa S; Yasui T; Taguchi K; Umemoto Y; Kojima Y; Kohri K
BMC Res Notes; 2014 Dec; 7():909. PubMed ID: 25512116
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of human papillomavirus infections in prostatic disease: a cross-sectional study in Iran.
Ghasemian E; Monavari SH; Irajian GR; Jalali Nodoshan MR; Roudsari RV; Yahyapour Y
Asian Pac J Cancer Prev; 2013; 14(5):3305-8. PubMed ID: 23803120
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and cervical cancer.
Berrington A; Jha P; Peto J; Green J; Hermon C;
Lancet; 2002 Aug; 360(9330):410. PubMed ID: 12241800
[No Abstract] [Full Text] [Related]
19. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Sutcliffe S; Giovannucci E; Gaydos CA; Viscidi RP; Jenkins FJ; Zenilman JM; Jacobson LP; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1573-80. PubMed ID: 17684131
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized.
Terris MK; Peehl DM
Urology; 1997 Jul; 50(1):150-6. PubMed ID: 9218040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
